Lopinavir

DRUG8 trials

Conditions

Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic OligodendrogliomaBrain Stem GliomaBrain TumorCOVIDCOVID-19Corona Virus Infection

Phase 2

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

CompletedNCT00056641

Boehringer IngelheimHIV Infections

Start: 2003-02-18Target: 328Updated: 2023-12-01

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

TerminatedNCT01095094

Case Comprehensive Cancer CenterAnaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma +6

Start: 2009-01-31End: 2011-11-30Updated: 2013-06-10

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)

TerminatedNCT02116660

Merck Sharp & Dohme LLCHIV Infections

Start: 2014-09-03End: 2017-07-10Updated: 2019-04-08

A Study of Combination Therapies to Treat COVID-19 Infection

WithdrawnNCT04459702

ProgenaBiomeCoronavirus-19, Coronavirus Infection, Corona Virus Infection +5

Start: 2020-07-31End: 2021-12-31Updated: 2021-04-08

Phase 3

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

WithdrawnNCT01255371

ANRS, Emerging Infectious DiseasesHIV

Start: 2012-03-31End: 2014-12-31Updated: 2012-11-08

Evaluation of Low-dose Darunavir in a Switch Study

CompletedNCT02671383

Willem Daniel Francois VenterHIV Infections

Start: 2016-06-30End: 2018-05-16Updated: 2018-06-26

Phase 4

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

CompletedNCT00771498

Oswaldo Cruz FoundationHIV Infection, Tuberculosis

Start: 2008-11-30End: 2012-12-31Updated: 2015-05-19

Unknown Phase

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

WithdrawnNCT01165645

Mayo ClinicHodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma +2

Start: 2010-11-30End: 2011-12-14Updated: 2022-12-01

Related Papers

Phone Calls to Retain Research Participants and Determinants of Reachability in an African Setting: Observational Study

JMIR Formative Research2020-08-107 citations

Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial.

2019-06-1213 citations